{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:53:27Z","timestamp":1790618007196,"version":"4.1.0"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.neuroscience.2026.02.035","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T16:11:56Z","timestamp":1771690316000},"page":"227-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Gene therapy targeting synaptopathy linked with Alzheimer\u2019s and Parkinson\u2019s disease"],"prefix":"10.1016","volume":"600","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6980-6761","authenticated-orcid":false,"given":"Siva Prasad","family":"Panda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Saraswat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikrant","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neuroscience.2026.02.035_b0005","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1515\/revneuro-2014-0072","article-title":"Temporal phases of long-term potentiation (LTP): myth or fact?","volume":"26","author":"Abbas","year":"2015","journal-title":"Rev. Neurosci."},{"issue":"37","key":"10.1016\/j.neuroscience.2026.02.035_b0010","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202302673","article-title":"Functional nanomaterials for the diagnosis of Alzheimer\u2019s Disease: recent progress and future perspectives","volume":"33","author":"Abdullah","year":"2023","journal-title":"Adv. Funct. Mater."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.02.035_b0015","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/s41593-023-01345-0","article-title":"Postsynaptic synucleins mediate endocannabinoid signaling","volume":"26","author":"Albarran","year":"2023","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.035_b0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/genes8020063","article-title":"AAV vector-mediated gene delivery to substantia nigra dopamine neurons: implications for gene therapy and disease models","volume":"8","author":"Albert","year":"2017","journal-title":"Genes"},{"key":"10.1016\/j.neuroscience.2026.02.035_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144636","article-title":"Medical applications of clustered regularly interspaced short palindromic repeats (CRISPR\/Cas) tool: a comprehensive overview","volume":"745","author":"Araldi","year":"2020","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.035_b0030","first-page":"580","article-title":"G2019S-LRRK2 mutation enhances MPTP-linked Parkinsonism in mice","volume":"29","author":"Arbez","year":"2019","journal-title":"Academic. Oup. Com."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130413","article-title":"Unexplored power of CRISPR-Cas9 in neuroscience, a multi-OMICs review","volume":"263","author":"Banazadeh","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.00204","article-title":"Synaptic plasticity in cortical inhibitory neurons: what mechanisms may help to balance synaptic weight changes?","volume":"14","author":"Bannon","year":"2020","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.035_b0045","first-page":"445","article-title":"AAV2-GDNF for Parkinson\u2019s disease: synaptic rescue and early clinical safety signals","volume":"27","author":"Bartus","year":"2019","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0050","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/ijms21010143","article-title":"Modeling resilience to damage in multiple sclerosis: plasticity meets connectivity","volume":"21","author":"Bassi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102047","article-title":"Healthy brain aging and delayed dementia in Texas rural elderly","volume":"91","author":"Basu","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13024-021-00457-0","article-title":"Knock-in models related to Alzheimer\u2019s disease: Synaptic transmission, plaques and the role of microglia","volume":"16","author":"Benitez","year":"2021","journal-title":"Mol. Neurodegener."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.02.035_b0065","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.neurobiolaging.2014.03.031","article-title":"Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer\u2019s disease","volume":"35","author":"Berchtold","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuroscience.2026.02.035_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131802","article-title":"Genome editing and its role in vaccine, diagnosis, and therapeutic advancement","volume":"269","author":"Bisht","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.035_b0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10048-016-0489-x","article-title":"Transcriptional regulation of long-term potentiation","volume":"17","author":"Bliim","year":"2016","journal-title":"Neurogenetics"},{"key":"10.1016\/j.neuroscience.2026.02.035_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00080","article-title":"Mechanisms of \u03b1-Synuclein induced synaptopathy in parkinson\u2019s disease","volume":"12","author":"Bridi","year":"2018","journal-title":"Front. Neurosci."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.02.035_b0085","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1134\/S000629792106002X","article-title":"DJ-1 protein and its role in the development of parkinson\u2019s disease: studies on experimental models","volume":"86","author":"Buneeva","year":"2021","journal-title":"Biochem. (mosc.)"},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.035_b0090","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1189\/jlb.72.3.417","article-title":"Macrophages in gene therapy: cellular delivery vehicles and in vivo targets","volume":"72","author":"Burke","year":"2002","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.035_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0100","first-page":"6","article-title":"Age-dependent modifications of AMPA receptor subunit expression levels and related cognitive effects in 3xTg-AD mice","author":"Cantanelli","year":"2014","journal-title":"Front. Aging Neurosci."},{"issue":"8","key":"10.1016\/j.neuroscience.2026.02.035_b0105","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3390\/biom14080949","article-title":"Novel therapeutic horizons: SNCA targeting in Parkinson\u2019s Disease","volume":"14","author":"Caramiello","year":"2024","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.neuroscience.2026.02.035_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103652","article-title":"CRISPR-Cas9 in Alzheimer\u2019s disease: therapeutic trends, modalities, and challenges","volume":"28","author":"Chacko","year":"2023","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102138","article-title":"Recent advances in CRISPR-Cas9-based genome insertion technologies","volume":"35","author":"Chen","year":"2024","journal-title":"Mol. Ther. Nucl. Acids"},{"issue":"5","key":"10.1016\/j.neuroscience.2026.02.035_b0120","doi-asserted-by":"crossref","first-page":"E750","DOI":"10.1152\/ajpendo.00179.2019","article-title":"Mitochondrial dysfunction plays a key role in the development of neurodegenerative diseases in diabetes","volume":"318","author":"Cheng","year":"2020","journal-title":"Am. J. Phys. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.npp.1301559","article-title":"Synaptic Plasticity: Multiple Forms, Functions, and Mechanisms","volume":"33","author":"Citri","year":"2007","journal-title":"Neuropsychopharmacol"},{"issue":"7","key":"10.1016\/j.neuroscience.2026.02.035_b0130","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1093\/brain\/awy117","article-title":"Tau reduction in the presence of amyloid-\u03b2 prevents tau pathology and neuronal death in vivo","volume":"141","author":"DeVos","year":"2018","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.035_b0135","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neuron.2018.10.018","article-title":"The AMPA receptor code of synaptic plasticity","volume":"100","author":"Diering","year":"2018","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.035_b0140","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/aps.2009.24","article-title":"Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases","volume":"30","author":"Dong","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0145","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/s41593-022-01131-4","article-title":"A CRISPRi\/a platform in human iPSC-derived microglia uncovers regulators of disease states","volume":"25","author":"Drager","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.02.035_b0150","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/brain\/awz065","article-title":"Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration","volume":"142","author":"Durante","year":"2019","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.neuroscience.2026.02.035_b0155","doi-asserted-by":"crossref","first-page":"7501","DOI":"10.1007\/s00210-024-03141-4","article-title":"In vivo and ex vivo gene therapy for neurodegenerative diseases: a promise for disease modification","volume":"397","author":"Ebrahimi","year":"2024","journal-title":"Naunyn-Schmiedeb. Arch. Pharmacol"},{"issue":"12","key":"10.1016\/j.neuroscience.2026.02.035_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226245","article-title":"Gene delivery of a modified antibody to A\u03b2 reduces progression of murine Alzheimer's disease","volume":"14","author":"Elmer","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2026.02.035_b0165","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40035-022-00279-0","article-title":"Brain-derived neurotrophic factor in Alzheimer\u2019s disease and its pharmaceutical potential","volume":"11","author":"Gao","year":"2022","journal-title":"Transl. Neurodegener"},{"key":"10.1016\/j.neuroscience.2026.02.035_b0170","doi-asserted-by":"crossref","unstructured":"Garza, I. T., Snyder, B., Holmes, S. K., Pearce, K. M., Knight, K., Bailey, R. M., 2025. Preclinical Development of a Vectorized Artificial miRNA Gene Therapy for Tauopathies. bioRxiv. 2025.10.12.681935.","DOI":"10.1101\/2025.10.12.681935"},{"key":"10.1016\/j.neuroscience.2026.02.035_b0175","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fneur.2018.00295","article-title":"Alpha-synuclein: from early synaptic dysfunction to neurodegeneration","volume":"9","author":"Ghiglieri","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0180","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13024-021-00455-2","article-title":"Identification of sixteen novel candidate genes for late onset Parkinson\u2019s disease","volume":"16","author":"Gialluisi","year":"2021","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.035_b0185","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3233\/JAD-2010-101080","article-title":"Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer\u2019s disease","volume":"22","author":"Ginsberg","year":"2010","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0190","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fnsyn.2019.00020","article-title":"Approaches and limitations in the investigation of synaptic transmission and plasticity","volume":"11","author":"Glasgow","year":"2019","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0200","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fonc.2019.00297","article-title":"Gene therapy leaves a vicious cycle","volume":"9","author":"Goswami","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0205","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fnins.2011.00100","article-title":"Expression of the AMPA receptor subunits GluR1 and GluR2 is associated with granule cell maturation in the dentate gyrus","volume":"5","author":"Hagihara","year":"2011","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0210","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1080\/15476286.2022.2066334","article-title":"Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases","volume":"19","author":"Holm","year":"2022","journal-title":"RNA Biol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep29152","article-title":"The reemergence of long-term potentiation in aged Alzheimer\u2019s disease mouse model","volume":"6","author":"Huh","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11064-012-0886-y","article-title":"Scaffolding proteins of the post-synaptic density contribute to synaptic plasticity by regulating receptor localization and distribution: relevance for neuropsychiatric diseases","volume":"38","author":"Iasevoli","year":"2013","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.035_b0225","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1523\/JNEUROSCI.4792-03.2004","article-title":"Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-beta peptide in mouse brain","volume":"24","author":"Iwata","year":"2004","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.02.035_b0230","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00702-020-02232-9","article-title":"Neuropathological assessment of the Alzheimer spectrum","volume":"127","author":"Jellinger","year":"2020","journal-title":"J. Neural Transm."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.02.035_b0235","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/ane.12563","article-title":"The genetic background of Parkinson\u2019s disease: current progress and future prospects","volume":"134","author":"Kalinderi","year":"2016","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0240","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2147\/NDT.S50371","article-title":"Animal models of epilepsy: use and limitations","volume":"10","author":"Kandratavicius","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.035_b0245","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3233\/JPD-201965","article-title":"Soluble endogenous oligomeric \u03b1-synuclein species in neurodegenerative diseases: Expression, spreading, and cross-talk","volume":"10","author":"Kayed","year":"2020","journal-title":"J Parkinson\u2019s Dis."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105754","article-title":"NADPH oxidase\u00a02 activity in Parkinson\u2019s disease","volume":"170","author":"Keeney","year":"2022","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0255","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/00207454.2018.1486837","article-title":"Awareness and current knowledge of Parkinson\u2019s disease: a neurodegenerative disorder","volume":"129","author":"Khan","year":"2019","journal-title":"Int. J. Neurosci."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.02.035_b0260","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrg3686","article-title":"A guide to genome engineering with programmable nucleases","volume":"15","author":"Kim","year":"2014","journal-title":"Nat. Rev. Genet."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.035_b0265","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1471-4159.2009.06152.x","article-title":"Impaired dopamine release and synaptic plasticity in the striatum of Parkin-\/- mice","volume":"110","author":"Kitada","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0270","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neuint.2017.07.007","article-title":"Application of the gene editing tool, CRISPR-Cas9, for treating neurodegenerative diseases","volume":"112","author":"Kolli","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104939","article-title":"Tau-mediated dysregulation of RNA: evidence for a common molecular mechanism of toxicity in frontotemporal dementia and other tauopathies","volume":"141","author":"Koren","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.035_b0280","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3233\/JAD-160623","article-title":"Stress\u2013induced synaptic dysfunction and neurotransmitter release in Alzheimer\u2019s disease: can neurotransmitters and neuromodulators be potential therapeutic targets?","volume":"57","author":"Jha","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.02.035_b0285","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1073\/pnas.1708754115","article-title":"DJ-1 deficiency impairs synaptic vesicle endocytosis and reavailability at nerve terminals","volume":"115","author":"Kyung","year":"2018","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.035_b0295","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10522-021-09910-5","article-title":"Aging and age\u2010related diseases: from mechanisms to therapeutic strategies","volume":"22","author":"Li","year":"2021","journal-title":"Biogerontology"},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.035_b0300","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.neurobiolaging.2008.05.013","article-title":"Neuronal gene expression in non-demented individuals with intermediate Alzheimer\u2019s Disease neuropathology","volume":"31","author":"Liang","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuroscience.2026.02.035_b0305","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2014.00022","article-title":"Striatal cholinergic interneuron regulation and circuit effects","volume":"6","author":"Lim","year":"2014","journal-title":"Front. Synaptic Neurosci."},{"issue":"35","key":"10.1016\/j.neuroscience.2026.02.035_b0310","doi-asserted-by":"crossref","first-page":"12005","DOI":"10.1523\/JNEUROSCI.0871-12.2012","article-title":"Actin Polymerization-Dependent increase in Synaptic Arc\/Arg3.1 Expression in the Amygdala is crucial for the Expression of Aversive memory Associated with Drug Withdrawal","volume":"32","author":"Liu","year":"2012","journal-title":"J. Neurosci."},{"issue":"2\u20133","key":"10.1016\/j.neuroscience.2026.02.035_b0315","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00429-010-0244-2","article-title":"Dendritic vulnerability in neurodegenerative disease: insights from analyses of cortical pyramidal neurons in transgenic mouse models","volume":"214","author":"Luebke","year":"2010","journal-title":"Brain Struct. Funct."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.035_b0320","doi-asserted-by":"crossref","first-page":"530","DOI":"10.15252\/embr.201541438","article-title":"Expression of A152T human tau causes age\u2010dependent neuronal dysfunction and loss in transgenic mice","volume":"17","author":"Maeda","year":"2016","journal-title":"EMBO Rep."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.035_b0325","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/hum.2012.172","article-title":"Efficient clinical scale gene modification via zinc finger nuclease\u2013targeted disruption of the HIV Co-receptor CCR5","volume":"2","author":"Maier","year":"2013","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0330","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2174\/1566523222666220328142427","article-title":"Gene therapy, a potential therapeutic tool for neurological and neuropsychiatric disorders: applications, challenges and future perspective","volume":"23","author":"Mani","year":"2023","journal-title":"Curr. Gene Ther."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0335","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/ph6010108","article-title":"Neurotransmitter CART as a new therapeutic candidate for Parkinson\u2019s disease","volume":"6","author":"Mao","year":"2013","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2026.02.035_b0340","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1385\/JMN:18:1-2:53","article-title":"Synaptic proteins in Alzheimer\u2019s disease","volume":"18","author":"Marksteiner","year":"2002","journal-title":"J. Mol. Neurosci."},{"issue":"12","key":"10.1016\/j.neuroscience.2026.02.035_b0345","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S1474-4422(10)70254-4","article-title":"Gene delivery of AAV2-neurturin (CERE-120) in Parkinson\u2019s disease: long-term expression and clinical outcomes","volume":"9","author":"Marks","year":"2010","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0405","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13041-022-00905-y","article-title":"Optogenetics: implications for Alzheimer\u2019s disease research and therapy","volume":"15","author":"Mirzayi","year":"2022","journal-title":"Mol. Brain"},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.035_b0350","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/hum.2011.220","article-title":"Long-term evaluation of AAV2-AADC gene therapy for Parkinson\u2019s disease","volume":"23","author":"Mittermeyer","year":"2012","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0355","article-title":"In vitro studies of neuronal networks and synaptic plasticity in invertebrates and in mammals using multielectrode arrays","volume":"2015","author":"Massobrio","year":"2015","journal-title":"Neural Plast."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.035_b0360","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF03159951","article-title":"Effects of elevated intracellular calcium levels on the cytoskeleton and tau in cultured human cortical neurons","volume":"15","author":"Mattson","year":"1991","journal-title":"Mol. Chem. Neuropathol."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.035_b0365","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40778-019-00162-1","article-title":"Human hematopoietic stem cells: concepts and perspectives on the biology and use of fresh versus in vitro\u2013generated cells for therapeutic applications","volume":"5","author":"Mayani","year":"2019","journal-title":"Curr. Stem Cell Rep."},{"issue":"7\u20138","key":"10.1016\/j.neuroscience.2026.02.035_b0370","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/14789450.2020.1831388","article-title":"The role of synaptic biomarkers in the spectrum of neurodegenerative diseases","volume":"17","author":"Mazzucchi","year":"2020","journal-title":"Expert Rev. Proteom."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.035_b0375","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s12640-019-00014-0","article-title":"Abundance of synaptic vesicle-related proteins in alpha-synuclein-containing protein inclusions suggests a targeted formation mechanism","volume":"35","author":"McCormack","year":"2019","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0380","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2023.1129036","article-title":"Alzheimer\u2019s disease as a synaptopathy: evidence for dysfunction of synapses during disease progression","volume":"15","author":"Meftah","year":"2023","journal-title":"Front. Synaptic Neurosci."},{"issue":"1\u20133","key":"10.1016\/j.neuroscience.2026.02.035_b0385","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2012.10.032","article-title":"Excitotoxicity: Bridge to various triggers in neurodegenerative disorders","volume":"698","author":"Mehta","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0390","article-title":"Delivery platforms for CRISPR\/Cas9 genome editing of glial cells in the central nervous system","volume":"3","author":"Meneghini","year":"2021","journal-title":"Front. Genome Edit."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102335","article-title":"Overlooked cases of mild cognitive impairment: Implications to early Alzheimer\u2019s disease","volume":"98","author":"Mian","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.035_b0400","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3390\/v12040460","article-title":"Battling neurodegenerative diseases with adeno-associated virus-based approaches","volume":"12","author":"Mijanovi\u0107","year":"2020","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.neuroscience.2026.02.035_b0410","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.3390\/ijms22126277","article-title":"Recent insights into the interplay of alpha-synuclein and sphingolipid signaling in Parkinson\u2019s Disease","volume":"22","author":"Motyl","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0415","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/s41591-023-02326-3","article-title":"Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer\u2019s disease: a phase 1b, randomized, placebo-controlled trial","volume":"29","author":"Mummery","year":"2023","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.02.035_b0420","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s13365-023-01181-9","article-title":"Predictors of hippocampal tauopathy in people with and at risk for human immunodeficiency virus infection","volume":"29","author":"Nader","year":"2023","journal-title":"J. Neurovirol."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.035_b0425","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/jnc.15561","article-title":"Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool","volume":"164","author":"Nicastro","year":"2023","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.035_b0430","doi-asserted-by":"crossref","first-page":"e1709","DOI":"10.1038\/cddis.2015.72","article-title":"Alzheimer\u2019s disease-related amyloid-\u03b2 induces synaptotoxicity in human iPS cell-derived neurons","volume":"6","author":"Nieweg","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0435","first-page":"567","article-title":"CRISPR\/Cas9 genome editing for neurodegenerative diseases","volume":"22","author":"Nojadeh","year":"2023","journal-title":"EXCLI J."},{"issue":"8","key":"10.1016\/j.neuroscience.2026.02.035_b0440","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2174\/1389202914666131210205839","article-title":"Mutations in PRKN and SNCA genes important for the progress of Parkinson's Disease","volume":"14","author":"Oczkowska","year":"2014","journal-title":"Curr. Genomics"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-017-0475-z","article-title":"CRISPR\/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer\u2019s PSEN2N141I neurons","volume":"5","author":"Ortiz-Virumbrales","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.02.035_b0450","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4252\/wjsc.v15.i7.687","article-title":"Neural stem cells for Parkinson\u2019s disease management: challenges, nanobased support, and prospects","volume":"15","author":"Oz","year":"2023","journal-title":"World J Stem Cells"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-022-00314-0","article-title":"CRISPR\/dCas9-Dnmt3a-mediated targeted DNA methylation of APP rescues brain pathology in a mouse model of Alzheimer\u2019s disease","volume":"11","author":"Park","year":"2022","journal-title":"Transl. Neurodegener"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0460","first-page":"1","article-title":"A logical network-based drug-screening platform for Alzheimer\u2019s disease representing pathological features of human brain organoids","volume":"12","author":"Park","year":"2021","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.neuroscience.2026.02.035_b0465","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3390\/jcm10081555","article-title":"Neuropathology of the brainstem to mechanistically understand and to treat alzheimer\u2019s disease","volume":"10","author":"Patthy","year":"2021","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.035_b0470","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1310\/tsr1604-282","article-title":"Brain plasticity and genetic factors","volume":"16","author":"Pearson-Fuhrhop","year":"2009","journal-title":"Top. Stroke Rehabil."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0475","article-title":"Revealing NOTCH-dependencies in synaptic targets associated with Alzheimer\u2019s disease","volume":"115","author":"Perna","year":"2021","journal-title":"Mo. Cell. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102069","article-title":"Unravelling of molecular biomarkers in synaptic plasticity of Alzheimer\u2019s disease: critical role of the restoration of neuronal circuits","volume":"91","author":"Pinky","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.02.035_b0485","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/mds.29024","article-title":"Alpha-synuclein is involved in DYT1 dystonia striatal synaptic dysfunction","volume":"37","author":"Ponterio","year":"2022","journal-title":"Mov. Disord."},{"issue":"PART A","key":"10.1016\/j.neuroscience.2026.02.035_b0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2013.09.018","article-title":"A role for tau at the synapse in Alzheimer\u2019s disease pathogenesis","volume":"76","author":"Pooler","year":"2014","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.neuroscience.2026.02.035_b0495","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nbt1125","article-title":"Gene targeting using zinc finger nucleases","volume":"23","author":"Porteus","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0500","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s11658-016-0020-2","article-title":"BAG2 structure, function and involvement in disease","volume":"21","author":"Qin","year":"2016","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0505","doi-asserted-by":"crossref","unstructured":"Rahman, M. U., Bilal, M., Shah, J. A., Kaushik, A., Teissedre, P. L., Kujawska, M., 2022. CRISPR-Cas9-based technology and its relevance to gene editing in Parkinson\u2019s Disease. Pharmaceutics 2022, 14 (6), 1252.","DOI":"10.3390\/pharmaceutics14061252"},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.035_b0510","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3233\/JAD-160612","article-title":"Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer\u2019s disease neurons","volume":"57","author":"Rajmohan","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102178","article-title":"Alzheimer\u2019s disease and Alzheimer\u2019s disease-related dementias in hispanics: identifying influential factors and supporting caregivers","volume":"93","author":"Rawat","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.035_b0520","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3233\/JAD-170256","article-title":"A critical assessment of research on neurotransmitters in Alzheimer's Disease","volume":"57","author":"Reddy","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"12","key":"10.1016\/j.neuroscience.2026.02.035_b0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165937","article-title":"The Role of Synaptic microRNAs in Alzheimer's Disease","volume":"1866","author":"Kumar","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.035_b0525","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3233\/JAD-2005-7203","article-title":"Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction","volume":"7","author":"Reddy","year":"2005","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.035_b0540","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/biomedicines11020355","article-title":"Detecting early cognitive decline in Alzheimer's disease with brain synaptic structural and functional evaluation","volume":"11","author":"Ribaric","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuroscience.2026.02.035_b0545","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00556","article-title":"LRRK2-related Parkinson\u2019s disease due to altered endolysosomal biology with variable lewy body pathology: a hypothesis","volume":"14","author":"Rivero-Rios","year":"2020","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.035_b0550","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13581","article-title":"AAV-mediated expression of secreted and transmembrane \u03b1Klotho isoforms rescues relevant aging hallmarks in senescent SAMP8 mice","volume":"21","author":"Roig-Soriano","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/j.neuroscience.2026.02.035_b0555","article-title":"Proteomic insight into Alzheimer\u2019s disease pathogenesis pathways","volume":"e202400298","author":"Ryu","year":"2025","journal-title":"Proteomics"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0560","doi-asserted-by":"crossref","first-page":"112","DOI":"10.15252\/emmm.201606965","article-title":"Lysosomal dysfunction disrupts presynaptic maintenance and restoration of presynaptic function prevents neurodegeneration in lysosomal storage diseases","volume":"9","author":"Sambri","year":"2017","journal-title":"EMBO Mol. Med."},{"issue":"11","key":"10.1016\/j.neuroscience.2026.02.035_b0565","first-page":"2970","article-title":"AAV-GBA1 gene delivery improves lysosomal function and synaptic integrity in PD models","volume":"140","author":"Sardi","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2026.02.035_b0570","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00318","article-title":"Gene expression parallels synaptic excitability and plasticity changes in Alzheimer\u2019s disease","volume":"9","author":"Saura","year":"2015","journal-title":"Front. Cellular Neurosci."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120375","article-title":"Gene therapy: Comprehensive overview and therapeutic applications","volume":"294","author":"Sayed","year":"2022","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.035_b0580","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00401-022-02526-0","article-title":"Functional excitatory to inhibitory synaptic imbalance and loss of cognitive performance in people with Alzheimer\u2019s disease neuropathologic change","volume":"145","author":"Scaduto","year":"2023","journal-title":"Acta Neuropathol."},{"issue":"10","key":"10.1016\/j.neuroscience.2026.02.035_b0585","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","article-title":"Hippocampal synaptic loss in early Alzheimer\u2019s disease and mild cognitive impairment","volume":"27","author":"Scheff","year":"2006","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.035_b0590","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201512R","article-title":"Deficiency of IKK\u03b2 in neurons ameliorates Alzheimer\u2019s disease pathology in APP- and tau-transgenic mice.the","volume":"37","author":"Schnoder","year":"2023","journal-title":"FASEB J."},{"issue":"24","key":"10.1016\/j.neuroscience.2026.02.035_b0595","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1523\/JNEUROSCI.1091-10.2010","article-title":"A pathologic cascade leading to synaptic dysfunction in \u03b1-synuclein-induced neurodegeneration","volume":"30","author":"Scott","year":"2010","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0600","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0301-0082(00)00021-6","article-title":"Rapid plasticity of dendritic spine: hints to possible functions?","volume":"63","author":"Segal","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102027","article-title":"Alzheimer\u2019s disease and its related dementias in US Native Americans: a major public health concern","volume":"90","author":"Sehar","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"21","key":"10.1016\/j.neuroscience.2026.02.035_b0610","doi-asserted-by":"crossref","first-page":"12924","DOI":"10.3390\/ijms232112924","article-title":"Amyloid beta in aging and Alzheimer\u2019s Disease","volume":"23","author":"Sehar","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.02.035_b0615","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0620","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.gendis.2019.01.004","article-title":"Impact of gene mutation in the development of Parkinson's disease","volume":"6","author":"Selvaraj","year":"2019","journal-title":"Genes Dis."},{"issue":"C","key":"10.1016\/j.neuroscience.2026.02.035_b0625","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuropharm.2013.07.009","article-title":"Molecular mechanisms of homeostatic synaptic downscaling","volume":"78","author":"Siddoway","year":"2014","journal-title":"Neuropharmacology"},{"issue":"22","key":"10.1016\/j.neuroscience.2026.02.035_b0630","doi-asserted-by":"crossref","first-page":"12311","DOI":"10.3390\/ijms252212311","article-title":"From Fundamentals to innovation in Alzheimer\u2019s disease: molecular findings and revolutionary therapies","volume":"25","author":"Sighencea","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.035_b0635","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.neurobiolaging.2013.09.032","article-title":"Role for the neurexin-neuroligin complex in Alzheimer's disease","volume":"35","author":"Sindi","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"8","key":"10.1016\/j.neuroscience.2026.02.035_b0640","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.3390\/pharmaceutics15082051","article-title":"Inhibition of protein aggregation and endoplasmic reticulum stress as a targeted therapy for \u03b1-synucleinopathy","volume":"15","author":"Siwecka","year":"2023","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.neuroscience.2026.02.035_b0645","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1212\/WNL.54.10.1960","article-title":"Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD","volume":"54","author":"Sjogren","year":"2000","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.035_b0650","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1515\/REVNEURO.2004.15.4.267","article-title":"Neuronal structure is altered by amyloid plaques","volume":"15","author":"Spires","year":"2004","journal-title":"Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.02.035_b0655","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1046\/j.1460-9568.2003.02800.x","article-title":"Timecourse of striatal re-innervation following lesions of dopaminergic SNpc neurons of the rat","volume":"18","author":"Stanic","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0660","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-biochem-080320-110356","article-title":"Repair of DNA double-strand breaks by the nonhomologous end joining pathway","volume":"90","author":"Stinson","year":"2021","journal-title":"Annu. Rev. Biochem"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0665","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/crispr.2021.0039","article-title":"Strategies for enhancing the homology-directed repair efficiency of CRISPR-cas systems","volume":"5","author":"Sun","year":"2022","journal-title":"CRISPR J."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0670","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/jnc.13580","article-title":"Neural plasticity and behavior \u2013 sixty years of conceptual advances","volume":"139","author":"Sweatt","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0675","article-title":"BDNF gene therapy rescues neuronal function via unique and common transcriptional responses in A\u03b2 and tau-driven Alzheimer's disease mouse models","volume":"43","author":"Tang","year":"2025","journal-title":"Biochem. Biophys. Rep."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.02.035_b0680","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.180138","article-title":"Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models","volume":"8","author":"Taoufik","year":"2018","journal-title":"Open Biol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0685","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MS9.0000000000001500","article-title":"Application of CRISPR\/Cas9 in the management of Alzheimer\u2019s disease and Parkinson\u2019s disease: a review","volume":"86","author":"Thapar","year":"2024","journal-title":"Ann. Med. Surg."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.035_b0690","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2016.03.005","article-title":"Acetylated tau obstructs KIBRA-mediated signaling in synaptic plasticity and promotes tauopathy-related memory loss","volume":"90","author":"Tracy","year":"2016","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.neuroscience.2026.02.035_b0695","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/cells13050434","article-title":"Firing alterations of neurons in Alzheimer\u2019s disease: are they merely a consequence of pathogenesis or a pivotal component of disease progression?","volume":"13","author":"Tzavellas","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.neuroscience.2026.02.035_b0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121918","article-title":"Spontaneous and familial models of Alzheimer\u2019s disease: challenges and advances in preclinical research","volume":"328","author":"Ulaganathan","year":"2023","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.035_b0705","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s12035-016-9745-1","article-title":"Posttranslational modifications regulate the postsynaptic localization of PSD-95","volume":"54","author":"Vallejo","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0710","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1196\/annals.1332.015","article-title":"The degeneration of dopamine neurons in Parkinson\u2019s disease: insights from embryology and evolution of the mesostriatocortical system","volume":"1035","author":"Vernier","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.02.035_b0715","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of glutamate and NMDA receptors in Alzheimer\u2019s Disease","volume":"57","author":"Wang","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.02.035_b0720","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s12035-015-9143-0","article-title":"The essential role of soluble A\u03b2 oligomers in Alzheimer\u2019s disease","volume":"53","author":"Wang","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0725","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12035-018-1082-0","article-title":"Extracellular alpha-synuclein oligomers induce Parkin S-nitrosylation: relevance to sporadic Parkinson\u2019s disease etiopathology","volume":"56","author":"Wilkaniec","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0730","article-title":"Viral vectors in neurodegenerative diseases: immune responses and therapeutic applications","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0735","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-021-00270-1","article-title":"The role of pathological tau in synaptic dysfunction in Alzheimer\u2019s diseases","volume":"10","author":"Wu","year":"2021","journal-title":"Transl. Neurodegener."},{"issue":"10","key":"10.1016\/j.neuroscience.2026.02.035_b0740","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.molmed.2024.07.003","article-title":"LRRK2 in Parkinson\u2019s disease: upstream regulation and therapeutic targeting","volume":"30","author":"Xiong","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0745","article-title":"Identification of key genes and signaling pathways associated with dementia with Lewy bodies and Parkinson\u2019s disease dementia using bioinformatics","volume":"14","author":"Xu","year":"2023","journal-title":"Front. Neurol."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.02.035_b0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107237","article-title":"Tau regulates Arc stability in neuronal dendrites via a proteasome-sensitive but ubiquitin-independent pathway","volume":"300","author":"Yakout","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0755","article-title":"Axonal transport deficits in the pathogenesis of diabetic peripheral neuropathy","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"12","key":"10.1016\/j.neuroscience.2026.02.035_b0760","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.3390\/molecules29122812","article-title":"Role of tau protein in neurodegenerative diseases and development of its targeted drugs: a literature review","volume":"29","author":"Yang","year":"2024","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.neuroscience.2026.02.035_b0770","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.parkreldis.2012.02.018","article-title":"Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson\u2019s disease","volume":"18","author":"Yonova-Doing","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0775","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/crispr.2021.0025","article-title":"CRISPR-Cas9 gene editing protects from the A53T-SNCA overexpression-induced pathology of Parkinson\u2019s disease in vivo","volume":"5","author":"Yoon","year":"2022","journal-title":"The CRISPR J."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.02.035_b0780","doi-asserted-by":"crossref","first-page":"459","DOI":"10.14336\/AD.2023.0718","article-title":"The role of glial cells in synaptic dysfunction: insights into Alzheimer's disease mechanisms","volume":"15","author":"Yu","year":"2024","journal-title":"Aging Dis."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.02.035_b0785","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1007\/s12035-015-9415-8","article-title":"The Role of MAPT in neurodegenerative diseases: genetics, mechanisms and therapy","volume":"53","author":"Zhang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0790","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3389\/fnagi.2018.00370","article-title":"New perspectives on roles of alpha-synuclein in Parkinson\u2019s Disease","volume":"10","author":"Zhang","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.02.035_b0795","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1104\/pp.112.205179","article-title":"Transcription activator-like effector nucleases enable efficient plant genome engineering","volume":"161","author":"Zhang","year":"2012","journal-title":"Plant Physiol."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0800","doi-asserted-by":"crossref","first-page":"400","DOI":"10.18433\/jpps31458","article-title":"Research progress on the vesicle cycle and neurological disorders","volume":"24","author":"Zhu","year":"2021","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0805","doi-asserted-by":"crossref","DOI":"10.3389\/fnint.2021.619160","article-title":"Dysfunction of synaptic vesicle endocytosis in Parkinson\u2019s Disease","volume":"15","author":"Zou","year":"2021","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.02.035_b0810","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.physiol.64.092501.114547","article-title":"Short-term synaptic plasticity","volume":"64","author":"Zucker","year":"2002","journal-title":"Annu. Rev. Physiol."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226001387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226001387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:04:07Z","timestamp":1773939847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452226001387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":158,"alternative-id":["S0306452226001387"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.02.035","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene therapy targeting synaptopathy linked with Alzheimer\u2019s and Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.02.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}